SEARCH

SEARCH BY CITATION

References

  • 1
    Parking DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J. Cancer incidence in five continents. 1994 World Health Statistics Annual (Vol 6). Lyon IARC Scientific Publications. 117129: World Health Organization. Geneva WHO; 1995.
  • 2
    Horiike N, Fujisawa T, Michitaka K, Tada K, Masumoto T, Iuchi H, Kojima N, et al. The effectiveness of interferon therapy on occurrence of hepatocellular carcinoma in chronic hepatitis C. Oncol Rep 1998; 5:11711174.MEDLINE
  • 3
    Bruix J. Treatment of hepatocellular carcinoma. Hepatology 1997; 25:259262.MEDLINE
  • 4
    Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Cote J, et al. A long-term follow-up study of asymptomatic hepatitis B surface antigen-positive carriers in Montreal. Gastroenterology 1994; 106:10001005.MEDLINE
  • 5
    McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150:10511054.MEDLINE
  • 6
    Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22:432438.MEDLINE
  • 7
    Kato Y, Nakata K, Omagari K, Furukawa R, Kusumoto Y, Mori I, Tajima H, et al. Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses. Cancer 1994; 74:22342238.MEDLINE
  • 8
    Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, Kumada H, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology 1993; 18:4753.MEDLINE
  • 9
    Benvegnu L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A. Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74:24422448.MEDLINE
  • 10
    Cottone M, Turri M, Caltagirone M, Parisi P, Orlando A, Fiorentino G, Virdone R, et al. Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein. J Hepatol 1994; 21:10291034.MEDLINE
  • 11
    Zoli M, Magalotti D, Bianchi G, Gueli C, Marchesini G, Pisi E. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996; 78:977985.MEDLINE
  • 12
    Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19:6166.MEDLINE
  • 13
    Borzio M, Bruno S, Roncalli M, Mels GC, Ramella G, Borzio F, Leandro G, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995; 108:812817.MEDLINE
  • 14
    Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985; 56:918928.MEDLINE
  • 15
    Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, Rodes J. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990; 12:753760.MEDLINE
  • 16
    Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996; 77:22172222.MEDLINE
  • 17
    Keeffe EB. Gastroenterology: Chronic Hepatitis. In: Scientific American Medicine. DaleDC and FedermanDD eds. New York. Healtheon/WebMD, 4.VIII(1-9).
  • 18
    Trevisani F, D'Intino PE, Morselli-Labate AM, Mazzella G, Accogli E, Caraceni P, Domenicali M, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 2001; 34:570575.MEDLINE
  • 19
    Gebo KA, Jenckes MW, Chander G, Torbenson MS, Ghanem KG, Herlong HF, Sulkowski MS, et al. Management of chronic hepatitis C. Evidence Report/Technology Assessment No. 60 (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-97-0006). AHRQ Publication No. 02-E030. Rockville, MD: Agency for Healthcare Research and Quality. July 2002.
  • 20
    Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, Taketa K, et al. Early recognition of hepatocellular carcinoma based on altered profiles of alpha-fetoprotein. N Engl J Med 1993; 328:18021806.MEDLINE
  • 21
    McNamara RL, Bass EB, Miller MR, Segal JB, Goodman SN, Kim NL, Robinson KA, et al. Management of new onset atrial fibrillation No. 12 (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-097-0006.) AHRQ Publication No. 01-E026. Rockville, MD: Agency for Healthcare Quality and Research; 2001.
  • 22
    Garbutt JC, West SL, Carey TS, Lohr KN, Crews FT. Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 1999; 281:13181325.MEDLINE
  • 23
    Schein OD, Friedman DS, Fleisher LA, Lubomski LH, Magaziner J, Spritz M, Kemper J, et al. Evidence Report/Technology Assessment No. 16 (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-097-0006.) AHRQ Publication No. 01-E017. Rockville, MD: Agency for Healthcare Research and Quality; 2001.
  • 24
    Solmi L, Primerano AMM, Gandolfi L. Ultrasound follow-up of patients at risk for hepatocellular-carcinoma—results of a prospective study on 360 cases. Am J Gastroenterol 1996; 91:11891194.MEDLINE
  • 25
    Tsuzurahara S, Sata M, Iwamoto O, Shichijo S, Kojiro M, Tanikawa K, Itoh K. Detection of MAGE-4 protein in the sera of patients with hepatitis-C virus-associated hepatocellular carcinoma and liver cirrhosis. Jpn J Cancer Res 1997; 88:915918.MEDLINE
  • 26
    Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A, et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 1998; 27:13941402.MEDLINE
  • 27
    Sassa T, Kumada T, Nakano S, Uematsu T. Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma. Eur J Gastroenterol Hepatol 1999; 11:13871392.MEDLINE
  • 28
    Raedle J, Roth WK, Oremek G, Caspary WF, Zeuzem S. Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis C. Dig Dis Sci 1995; 40:25872594.MEDLINE
  • 29
    Kakumu S, Okumura A, Ishikawa T, Yano M, Enomoto A, Nishimura H, Yoshioka K, et al. Serum levels of Il-10, Il-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease. Clin Exp Immunol 1997; 109:458463.MEDLINE
  • 30
    Izzo F, Cremona F, Delrio P, Leonardi E, Castello G, Pignata S, Daniele B, et al. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol 1999; 6:178185.MEDLINE
  • 31
    Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, et al. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Am J Gastroenterol 2000; 95:10361040.MEDLINE
  • 32
    Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001; 16:553559.MEDLINE
  • 33
    Izzo F, Cremona F, Ruffolo F, Palaia R, Parisi V, Curley SA. Outcome of 67 patients with hepatocellular cancer detected during screening of 1125 patients with chronic hepatitis. Ann Surg 1998; 227:513518.MEDLINE
  • 34
    Colombo M, Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991; 325:675.MEDLINE
  • 35
    Larcos G, Sorokopud H, Berry G, Farrell GC. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. AJR Am J Roentgenol 1998; 171:433435.MEDLINE
  • 36
    Tradati F, Colombo M, Mannucci PM, Rumi MG, De Fazio C, Gamba G, Ciavarella N, et al. A prospective multicenter study of hepatocellular carcinoma in Italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers. Blood 1998; 91:11731177.MEDLINE
  • 37
    Nomura F, Ishijima M, Horikoshi A, Nakai T, Ohnishi K. Determination of serum des-gamma-carboxy prothrombin levels in patients with small-sized hepatocellular carcinoma: comparison of the conventional enzyme immunoassay and two modified methods. Am J Gastroenterol 1996; 91:13801383.MEDLINE
  • 38
    Nagai T, Murota M, Nishioka M, Fujita J, Ohtsuki Y, Dohmoto K, Hojo S, et al. Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significance. Eur J Gastroenterol Hepatol 2001; 13:157161.MEDLINE
  • 39
    Tsai JF, Jeng JE, Ho MS, Chang WY, Lin ZY, Tsai JH. Clinical evaluation of serum alpha-fetoprotein and circulating immune complexes as tumour markers of hepatocellular carcinoma. Br J Cancer 1995; 72:442446.MEDLINE
  • 40
    Tsai JF, Jeng JE, Chuang LY, Chang WY, Tsai JH. Urinary transforming growth factor beta(1) levels in hepatitis C virus-related chronic liver disease: correlation between high levels and severity of disease. Hepatology 1997; 25:11411146.MEDLINE
  • 41
    VanRoey G, Fevery J, VanSteenbergen W. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients. Eur J Gastroenterol Hepatol 2000; 12:6166.MEDLINE
  • 42
    Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Mazziotti A, Grazi GL, et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Cancer 1995; 75:22202232.MEDLINE
  • 43
    Tsai J-F, Chang WY, Jeng JE, Ho MS, Lin ZY, Tsai JH. Frequency of raised alpha-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and C. Br J Cancer 1994; 69:11571159.MEDLINE
  • 44
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, et al. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients. Hepatogastroenterology 2000; 47:16541658.MEDLINE
  • 45
    Zaman SN, Melia WM, Johnson RD, Portmann BC, Johnson PJ, Williams R. Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients. Lancet 1985; 1:13571360.MEDLINE
  • 46
    Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study. Hepatology 1997; 25:754758.MEDLINE
  • 47
    Di Bisceglie AM, Hoofnagle JH. Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer 1989; 64:21172120.MEDLINE
  • 48
    Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998; 27:273278.MEDLINE
  • 49
    Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, Coderc E, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994; 20:6571.MEDLINE
  • 50
    Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985; 89:259266.MEDLINE
  • 51
    Prorok PC. Epidemiologic approach for cancer screening. Problems in design and analysis of trials. Am J Pediatr Hematol Oncol 1992; 14:117128.MEDLINE